Apoptotic and anti-proliferative effects of 17β-estradiol and 17β-estradiol-like compounds in the Hep3B cell line

Molecular and Cellular Biochemistry

Volumn 290, Issue 1-2, 2006, Pages 1-7

  Huang, Erh Jung ^a   Wu, Cheng Chung ^b   Huang, Hsien Ping ^c   Liu, Jer Yuh ^c   Lin, Chung Sheng ^c   Chang, Yan Zin ^c   Lin, James A ^d   Lin, Jaung Geng ^e   Chen, Li Mien ^g   Lee, Shin Da ^c   Kuo, Wei Wen ^f   Huang, Chih Yang ^f  

^a CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^e Graduate Institute of Chinese Medical Science   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

17 estrodiol; 17 estrodiol like compounds; apoptotic and antiproliferative effects; Hepatocellular carcinoma (HCC)

Indexed keywords

CASPASE 3; CYTOCHROME C; DIETHYLSTILBESTROL; DNA FRAGMENT; ESTRADIOL; GENISTEIN; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE ARREST; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MITOCHONDRION; MITOSIS INHIBITION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGENS, NON-STEROIDAL; GENISTEIN; HUMANS; LIVER;

EID: 33749186065     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9000-y     Document Type: Article

References (31)

1. Babenko NA, Ruioz-Larrea MB, Lacort M: Inhibition by estrogens of the oxidant-mediated mobilization of arachidonic acid in hepatoctes. J Physiol Biochem 54: 77-84, 1998
2. Baird DD, Umbach DM, Lansdell L, Hughes CL, Sethell KDR: Dietary intervention study to assess estrogenicity of dietraayr soy among post-menopausal women. J Clin Endocrinol Metab 80: 1685-1690, 1995
3. Chao Y, Chan WK, Huang YS, Teng HC, Wang SS, Lui WY, Whang-Peng J, Lee SD: Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 77: 635-639, 1996
4. De Maria N, Manno M, Villa E: Sex hormones and liver cancer. Mol Cell Endocrinol 193: 59-63, 2002
5. Drinkwater NR: The interaction of genes and hormones in murine hepatocarcinogenesis. In: A. Cockburn, L. Smith (eds), Nongenotoxic carcinogenesis. New York: Springer-Verlag, pp. 219-230, 1994
6. Eagton PK, Francavilla A, Dileo A: Quantitation of estrogen and androgen receptors in hepatocellular cardcinoma and adjacent normal human liver. Digest Dis Sci 36: 1303-1308, 1991
7. El-Serag HB: HepatocAlullar carcinoma: an epidemiologic view. J Clin Gastroenterol 35: S72-S78, 2002
8. Farinati F, De Maria N, Marafin C, Fagiuoli S, Della Libera G, Naccarato R: Hepatocellular carcinoma in alcoholic ciIrhosis: is sex hormone imbalance a pathogenetic factor. Rur J Gastraoaenterol Hepatol 7: 145-150, 1995
9. Grimaldi C, Bleibeg H, Gay F, Messner M, Uougier P, Kok TC, Cirera L, Cervantes A, De Greve J, Pailot B, Buset M, Nitti D, Sahmoud T, Duez N, Wils, J: Evaluation of antiandrogen therapy in unrespectable hepatocellular carcinoma: Results of a European Organization for Research and Treatment of Cancer multicentric double blind trial. J Clin Oncol 16: 411-417, 1998
10. Grodstein F, Stampfer MJ: The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 38: 199-210, 1995
11. Guengerich FP: Rytochrome P450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1-17, 1999
12. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139, 1974
13. Hall JM, Couse JF, Korach KS: The multifaceted mechanisms ofestradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872, 2001
14. Herrmann M, Lorejz HM, Voll R, Grunke M, Woith W, Kalden JR: A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Research 22: 5506-5507, 1994
15. Keal AM, Lacort M: Cytoprotective Actions of estrogens against tert-Butyl hydroperoxide-induced Toxicity in hepatocytes. Biochem Pharmacol. 56: 1463-1469, 1998
16. Lei B, Roncaglia B, Vigano R, Ctrmonini C, Maria ND, Buono MGD, Manenti D, Villa E: Phytoestrogens and liver disease. Mol Cell Endocrinol 193: 81-81, 2002
17. Lin HL, Liu TY, Chau GY, Lui WY, Chi CW: Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cell and its correlation with reactive oxygen species. Cancer 89: 983-994, 2000
18. Liu M, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price HR, Pestell RG, Kushner PJ: Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277: 24353-24360, 2002
19. Lowry OH, Roseborough NJ, Far AL, Randall AJ: Protein measurement with the folin reagent. J Biol Chem 193: 265-275, 1951
20. Marselos M, TomatPs L: Diethylstibestrol, II: pharmacology, toxicology, and carcinogenicity in experimental animals. Eur J Cancer 29A: 149-155, 1993
21. Montalto G, Miceli, MD, Coresi M, Amodio R, Carroccio, A, Cartabellotta A, Castagneta L: Sex hormones in patients with liver cirrhosis and hepatocellular carcinoma. Oncol. Rep 4: 173-176, 1997
22. Pelzer T, Neuman M, Neyses L: 17 beta-estradiol prevents programmed cell death in cardiac myocytes. Bioch Biophy Res Communication 268: 192-200, 2000
23. Ren Z, Yanng B, Ye S: Estrogen receptor expression and its relationshoip with biologic feature in hepatocellular carcinoma. Zhonghua Zhohg Liu Za Zhi 19: 10-13, 1997
24. Ruioz-Larrea MB, Leal AM, Martin C, Lacort M: Antioxidant action of estrogen in rat hepatocytes. Rev Esp Fisiol Jun 53: 225-229, 1997
25. Shimizu I, Inoue H, Yano M, Shinomiya H, Wada S, Tsuji Y, Tsutsui A, Okamura S, Shibata H, Ito S: Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection. Liver 21: 342-349, 2001
26. Shimizu A, Yasuda M, Ito S: Suppressive effect of oestradiol on chemical hepatocarcinogenesis in rats. Gut 42: 112-119, 1998
27. Szafran H, Smielak-Korombel W: The role of estrogens in hormonal regulation of lipid metabolism in women. Przegl Lek 55: 266-270, 1998
28. Tan CK, Chow PK, Findlay M, Wong C, Machin D: Use of tamoxifen in hepatocellular carcinoma: A review and paradigm shift. J Gastroenterology and Hepoaatology 15: 725-729, 2000
29. Villa E, Grottola E, Colantoni A, Maria ND, Buttafoco P, Ferretti IV, Manenti F: Hepatocelllar carcinoma role of estrogen receptors in the liver. Annals of the New York Academy of Science 963: 37-45, 2002
30. Wang TT, Phang JM: Effects of estrogen on apoptotic pathway in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995
31. Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208: 124-130, 1995